spironolactone has been researched along with carbenoxolone sodium in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (35.00) | 18.7374 |
1990's | 7 (35.00) | 18.2507 |
2000's | 4 (20.00) | 29.6817 |
2010's | 2 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Cross, S; Hole, D; Rees, WD; Rhodes, J | 1 |
Edmonds, CJ | 1 |
Edmonds, CJ; Tomkins, AM | 1 |
Lindup, WE; Parke, DV; Shillingford, JS; Smith, MJ | 1 |
Gomez-Sanchez, CE; Gomez-Sanchez, EP | 1 |
Morris, DJ; Souness, GW | 2 |
Funder, JW; Myles, K; Pearce, PT; Roy, LP | 1 |
Baumgarten, IM; Davidson, JS; Harley, EH | 1 |
Adam, WR; Armanini, D; Funder, JW; Karbowiak, I; Krozowski, Z | 1 |
Edwards, CR; Sang, KS; Walker, BR; Williams, BC | 1 |
Khoo, K; Krozowski, ZS; Li, KX; Sheppard, KE | 1 |
Fadzilah, S; Hamid, A; Khalid, BA; Morat, PB; Nwe, KH | 1 |
Davies, SN; Gwyn, P; Ross, FM; Spanswick, D | 1 |
Dilley, R; Funder, JW; Moussa, L; Young, MJ | 1 |
Dong, Q; Ge, RS; Hardy, MP; Latif, SA; Morris, DJ; Sottas, CM | 1 |
Chepkova, AN; Haas, HL; Sergeeva, OA | 1 |
1 review(s) available for spironolactone and carbenoxolone sodium
Article | Year |
---|---|
Electrical potential difference of colonic mucosa.
Topics: Aldosterone; Biological Transport, Active; Carbenoxolone; Colitis; Colon; Dinitrophenols; Electrodes; Electrophysiology; Epithelium; Humans; Intestinal Mucosa; Ouabain; Proctitis; Sodium; Spironolactone | 1975 |
1 trial(s) available for spironolactone and carbenoxolone sodium
Article | Year |
---|---|
Carbenoxolone sodium for gastric ulcer.
Topics: Benzothiadiazines; Body Weight; Carbenoxolone; Clinical Trials as Topic; Diuretics; Duodenal Ulcer; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Sodium Chloride Symporter Inhibitors; Spironolactone; Stomach Ulcer; Triterpenes | 1975 |
18 other study(ies) available for spironolactone and carbenoxolone sodium
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The effect of an aldosterone antagonist on the protective action of carbenoxolone on the gastric mucosal barrier.
Topics: Animals; Bile; Carbenoxolone; Dogs; Gastric Mucosa; Hydrogen-Ion Concentration; Mineralocorticoid Receptor Antagonists; Sodium; Spironolactone; Stomach; Time Factors; Triterpenes | 1975 |
Electrical potential difference, sodium absorption and potassium secretion by the human rectum during carbenoxolone therapy.
Topics: Adult; Aged; Amiloride; Bendroflumethiazide; Carbenoxolone; Dialysis; Electrophysiology; Humans; Hydrocortisone; Intestinal Absorption; Intestinal Mucosa; Middle Aged; Peptic Ulcer; Potassium; Rectum; Sodium; Spironolactone; Triterpenes | 1975 |
Proceedings: The effects of ulcerogenic and ulcer-healing drugs on gastric mucus.
Topics: Animals; Carbenoxolone; Gastric Mucins; Gastric Mucosa; Glycoproteins; Humans; Indomethacin; Phenylbutazone; Rats; Spironolactone; Triterpenes | 1975 |
Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone.
Topics: Administration, Oral; Animals; Blood Pressure; Brain; Carbenoxolone; Corticosterone; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hypertension; Injections, Intraventricular; Male; Rats; Rats, Sprague-Dawley; Spironolactone | 1992 |
The "mineralocorticoid-like" actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318.
Topics: Adrenalectomy; Aldosterone; Animals; Carbenoxolone; Corticosterone; Creatinine; Desoxycorticosterone; Male; Mineralocorticoids; Natriuresis; Potassium; Rats; Receptors, Mineralocorticoid; Receptors, Steroid; Spironolactone | 1991 |
Apparent mineralocorticoid excess, pseudohypoaldosteronism, and urinary electrolyte excretion: toward a redefinition of mineralocorticoid action.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenalectomy; Aldosterone; Androstanols; Animals; Bicarbonates; Carbenoxolone; Child; Electrolytes; Female; Humans; Hydrocortisone; Hydroxysteroid Dehydrogenases; Male; Mifepristone; Mineralocorticoids; Natriuresis; Pseudohypoaldosteronism; Rats; Rats, Inbred Strains; Receptors, Mineralocorticoid; Receptors, Steroid; Spironolactone | 1990 |
Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid.
Topics: Carbenoxolone; Cell Communication; Cell Line; Citrulline; Dose-Response Relationship, Drug; Glycyrrhetinic Acid; Humans; Intercellular Junctions; Spironolactone; Tetradecanoylphorbol Acetate | 1986 |
The mechanism of mineralocorticoid action of carbenoxolone.
Topics: Adrenalectomy; Aldosterone; Animals; Carbenoxolone; Drug Interactions; Female; Glycyrrhetinic Acid; Kidney; Mineralocorticoids; Potassium; Rats; Rats, Inbred Strains; Receptors, Mineralocorticoid; Receptors, Steroid; Sodium; Spironolactone | 1982 |
Direct and indirect effects of carbenoxolone on responses to glucocorticoids and noradrenaline in rat aorta.
Topics: Adrenalectomy; Animals; Aorta; Carbenoxolone; Corticosterone; Glucocorticoids; In Vitro Techniques; Male; Mifepristone; Norepinephrine; Rats; Rats, Wistar; Spironolactone; Vasoconstriction | 1994 |
11-Dehydrocorticosterone in the presence of carbenoxolone is a more potent sodium retainer than corticosterone.
Topics: Adrenalectomy; Animals; Carbenoxolone; Corticosterone; Creatinine; Male; Mineralocorticoid Receptor Antagonists; Natriuresis; Potassium; Rats; Rats, Sprague-Dawley; Spironolactone | 1993 |
Steroid specificity of the putative DHB receptor: evidence that the receptor is not 11betaHSD.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Carbenoxolone; Cell Nucleus; Cells, Cultured; CHO Cells; Colon; Corticosterone; Cricetinae; Culture Media, Conditioned; Hydroxysteroid Dehydrogenases; Intestinal Mucosa; Male; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Spironolactone; Substrate Specificity; Transfection | 1998 |
Novel effects of deoxycorticosterone on testicular 11beta-hydroxysteroid dehydrogenase activity and plasma testosterone levels in normal and adrenalectomized rats.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenal Glands; Adrenalectomy; Animals; Carbenoxolone; Desoxycorticosterone; Hydroxysteroid Dehydrogenases; Male; Progesterone; Rats; Rats, Wistar; Reference Values; Spironolactone; Testis; Testosterone | 1999 |
Carbenoxolone depresses spontaneous epileptiform activity in the CA1 region of rat hippocampal slices.
Topics: Animals; Carbenoxolone; Depression, Chemical; Epilepsy; Female; Gap Junctions; Hippocampus; Hydrogen-Ion Concentration; In Vitro Techniques; Intracellular Fluid; Mineralocorticoid Receptor Antagonists; Octanols; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Spironolactone; Synaptic Transmission | 2000 |
Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Blood Pressure; Carbenoxolone; Cardiomegaly; Coronary Disease; Desoxycorticosterone; Enzyme Inhibitors; Eplerenone; Fibrosis; Heart; Hydroxysteroid Dehydrogenases; Kidney; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocardium; Nephrectomy; Organ Size; Rats; Rats, Sprague-Dawley; Sodium Chloride; Solutions; Spironolactone; Vasculitis | 2003 |
Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Animals; Binding Sites; Carbenoxolone; Corticosterone; Drug Synergism; In Vitro Techniques; Leydig Cells; Male; Mineralocorticoid Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Testosterone | 2005 |
Carbenoxolone impairs LTP and blocks NMDA receptors in murine hippocampus.
Topics: Adrenal Cortex Hormones; Animals; Calcium Channel Blockers; Carbenoxolone; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; Hormone Antagonists; In Vitro Techniques; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Mifepristone; Receptors, N-Methyl-D-Aspartate; Spironolactone; Taurine | 2008 |